Biocytom GBX SRL
Biocytom GBX reported total assets of €1.44m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 May 2026).
By total assets for 2025, Biocytom GBX ranks among the 200 largest of the 500 companies in its sector (NACE 8691) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Biocytom GBX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +19 % Total assets +46 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biocytom GBX's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 117,830 € | ||||
| Equity | 587,744 € | ||||
| Cash | 428,934 € | ||||
| EBITDA | 188,746 € | ||||
| Total assets | €1.44m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 May 2026
- Year ended 31 Dec 2024filed on 10 Jun 2025
- Year ended 31 Dec 2023filed on 20 Jun 2024
- Year ended 31 Dec 2022filed on 22 Jun 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Biocytom GBX's financial analysis
- Solvency40.9%sector median: 66.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biocytom GBX
Biocytom GBX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0543.497.928
- VAT number
- BE0543497928
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 20 Dec 2013
- Registered office
- 5030 Gembloux
- Latest accounts
- 2025 · filed on 27 May 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
Biocytom GBX (SRL) has been based in Gembloux since 2013, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net profit of 117,830 € and equity of 587,744 €; its revenue is not published. Its solvency stands at 40.9%, below the median of its sector (66.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biocytom GBX
Companies in the same business, of comparable size and area, outside its group.
- Dr. Delaunoy Ingrid,Fysische Geneeskunde Diagnostic imaging services and medical laboratory activities Beersel · balance sheet €1.67m
- Arts-Psychiater Lieven de Weirdt Diagnostic imaging services and medical laboratory activities Sint-Niklaas · balance sheet €1.28m
- Dokter Plasman Koen,Huisarts Diagnostic imaging services and medical laboratory activities Pajottegem · balance sheet €1.27m
- Medisch Kabinet Dr. Jan Laenens - Huisarts Diagnostic imaging services and medical laboratory activities Aarschot · balance sheet €1.71m
- Oncurious Diagnostic imaging services and medical laboratory activities Brussels · balance sheet 160,462 €
- Chrometra Diagnostic imaging services and medical laboratory activities Kortenaken · balance sheet 97,221 €
- FHP Diagnostic imaging services and medical laboratory activities Bornem · balance sheet 773,222 €
- Technolis Diagnostic imaging services and medical laboratory activities Andenne · balance sheet 72,079 €
Frequently asked questions about Biocytom GBX
What is the revenue of Biocytom GBX?
Biocytom GBX files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biocytom GBX?
In Belgium, the VAT number is the company number prefixed with BE: BE0543497928 for Biocytom GBX, if the company is VAT-registered. Its company number (CBE) is 0543.497.928.
Where is the registered office of Biocytom GBX?
According to the CBE register, the registered office of Biocytom GBX is in 5030 Gembloux.
What is the equity of Biocytom GBX?
At the close of the 2025 financial year, the equity of Biocytom GBX amounts to 587,744 €, a solvency of 40.9% of total assets.
Who manages Biocytom GBX?
The register lists 1 active mandates at Biocytom GBX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Biocytom GBX within its sector?
By total assets for 2025, Biocytom GBX ranks among the 200 largest of the 500 companies in its sector (NACE 8691) in Belgium that filed accounts for that financial year.
The full file of Biocytom GBX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →